Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Iridex Corp changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of IRIX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders2932+3
Shares3.50M3.51M+12.3K (+0.4%)
Value$26.8M$21.4M−$5.35M (−20.0%)

New holders (7)

Institutions that held Iridex Corp at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to IRIX in Q4 2021
InstitutionSharesValue% of portfolio
Punch & Associates Investment Management, Inc.110,024$672.0K0.04%
Long Focus Capital Management, LLC100,000$611.0K0.17%
StoneX Group Inc.21,400$130.8K0.02%
Two Sigma Advisers, LP18,700$114.0K0.00%
Two Sigma Investments, LP15,100$92.0K0.00%
US Bancorp210$1.00K0.00%
Bank of America Corp17$00.00%

Sold out (4)

Institutions that held Iridex Corp at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of IRIX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
JPMorgan Chase & Co16,535$127.0K
Millennium Management LLC12,712$97.0K
Simplex Trading, LLC1,827$12.0K
O'Shaughnessy Asset Management, LLC400$3.00K